Characterization of BBB permeability in a preclinical model of cryptococcal meningoencephalitis using magnetic resonance imaging

Journal of Cerebral Blood Flow and Metabolism

Volumn 29, Issue 3, 2009, Pages 545-553

  Pai, Manjunath P ^a   Sakoglu, Unal ^b   Peterson, Steven L ^a   Lyons, C Richard ^c   Sood, Rohit ^b,c,d  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d MRI Core   (United States)

Author keywords

Animal model; Cryptococcus; Meningoencephalitis; MRI; Rat

Indexed keywords

BIOLOGICAL MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; COLONY FORMING UNIT; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCUS NEOFORMANS; DIFFUSION WEIGHTED IMAGING; DISEASE MARKER; HISTOPATHOLOGY; INOCULATION; LUNG; MENINGOENCEPHALITIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERMEABILITY BARRIER; PRIORITY JOURNAL; RAT; SPLEEN;

ANIMALS; BLOOD-BRAIN BARRIER; CAPILLARY PERMEABILITY; CEREBRAL CORTEX; CRYPTOCOCCUS NEOFORMANS; DISEASE MODELS, ANIMAL; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MENINGITIS, CRYPTOCOCCAL; RATS; RATS, INBRED F344; TIME FACTORS;

EID: 61349103666     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2008.144     Document Type: Article

References (32)

1. Berkefeld J, Enzensberger W, Lanfermann H (1999) Cryptococcus meningoencephalitis in AIDS: parenchymal and meningeal forms. Neuroradiology 41:129-33
2. Bicanic T, Harrison TS (2004) Cryptococcal meningitis. Br Med Bull 72:99-118
3. Brouwer AE, Teparrukkul P, Pinpraphaporn S, Larsen RA, Chierakul W, Peacock S, Day N, White NJ, Harrison TS (2005) Baseline correlation and comparative kinetics of cerebrospinal fluid colony-forming unit counts and antigen titers in cryptococcal meningitis. J Infect Dis 192:681-4
4. Carroll SF, Guillot L, Qureshi ST (2007) Mammalian model hosts of cryptococcal infection. Comp Med 57:9-17
5. Charlier C, Chretien F, Baudrimont M, Mordelet E, Lortholary O, Dromer F (2005) Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am J Pathol 166:421-32
6. Collett G, Parrish A (2007) Fluconazole donation and outcomes assessment in cryptococcal meningitis. S Afr Med J 97:175-6
7. Dromer F, Mathoulin-Pelissier S, Launay O, Lortholary O (2007) Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLoS Med 4:e21
8. Ewing JR, Knight RA, Nagaraja TN, Yee JS, Nagesh V, Whitton PA, Li L, Fenstermacher JD (2003) Patlak plots of Gd-DTPA MRI data yield blood-brain transfer constants concordant with those of 14C-sucrose in areas of blood-brain opening. Magn Reson Med 50:283-92
9. Friedman GD, Jeffrey Fessel W, Udaltsova NV, Hurley LB (2005) Cryptococcosis: the 1981-2000 epidemic. Mycoses 48:122-5
10. Fries BC, Lee SC, Kennan R, Zhao W, Casadevall A, Goldman DL (2005) Phenotypic switching of Cryptococcus neoformans can produce variants that elicit increased intracranial pressure in a rat model of cryptococcal meningoencephalitis. Infect Immun 73:1779-87
11. Goldman DL, Casadevall A, Cho Y, Lee SC (1996) Cryptococcus neoformans meningitis in the rat. Lab Invest 75:759-70
12. Gultasli NZ, Ercan K, Orhun S, Albayrak S (2007) MRI findings of intramedullary spinal cryptococcoma. Diagn Interv Radiol 13:64-7
13. Iyer RS, Banker DD (2002) Cryptococcal meningitis in AIDS. Indian J Med Sci 56:593-7
14. Kalra A, Bansal M (2004) Postmortem pathology of opportunistic infection in a HIV positive patient - a case report. Indian J Pathol Microbiol 47:248-50
15. Kisenge PR, Hawkins AT, Maro VP, McHele JP, Swai NS, Mueller A, Houpt ER (2007) Low CD4 count plus coma predicts cryptococcal meningitis in Tanzania. BMC Infect Dis 7:39
16. Kuroki M, Phichaichumpon C, Yasuoka A, Chiranairadul P, Chosa T, Sirinirund P, Miyazaki T, Kakeya H, Higashiyama Y, Miyazaki Y, Ishida Y, Kohno S (2004) Environmental isolation of Cryptococcus neoformans from an endemic region of HIV-associated cryptococcosis in Thailand. Yeast 21:809-12
17. Lakshmi V, Sudha T, Teja VD, Umabala P (2007) Prevalence of central nervous system cryptococcosis in human immunodeficiency virus reactive hospitalized patients. Indian J Med Microbiol 25:146-9
18. Lortholary O (2007) Management of cryptococcal meningitis in AIDS: the need for specific studies in developing countries. Clin Infect Dis 45:81-3
19. Lui G, Lee N, Ip M, Choi KW, Tso YK, Lam E, Chau S, Lai R, Cockram CS (2006) Cryptococcosis in apparently immunocompetent patients. QJM 99:143-51
20. McCarthy KM, Morgan J, Wannemuehler KA, Mirza SA, Gould SM, Mhlongo N, Moeng P, Maloba BR, Crewe-Brown HH, Brandt ME, Hajjeh RA (2006) Population-based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence. AIDS 20:2199-206
21. Miszkiel KA, Hall-Craggs MA, Miller RF, Kendall BE, Wilkinson ID, Paley MN, Harrison MJ. (1996) The spectrum of MRI findings in CNS cryptococcosis in AIDS. Clin Radiol 51:842-50
22. Mitchell TG, Perfect JR (1995) Cryptococcosis in the era of AIDS - 100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 8:515-48
23. Mwaba P, Mwansa J, Chintu C, Pobee J, Scarborough M, Portsmouth S, Zumla A (2001) Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions. Postgrad Med J 77:769-73
24. Narai H, Manabe Y, Deguchi K, Iwatsuki K, Sakai K, Abe K (2001) Serial MRI findings in patient with chronic cryptococcus meningo-encephalitis. Neurol Res 23:810-2
25. Perfect JR, Lang SD, Durack DT (1980) Chronic cryptococcal meningitis: a new experimental model in rabbits. Am J Pathol 101:177-94
26. Rosen S, Sanne I, Collier A, Simon JL (2005) Rationing antiretroviral therapy for HIV/AIDS in Africa: choices and consequences. PLoS Med 2:e303
27. Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, Sobel JD, Dismukes WE (2000) Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 30:710-8
28. Sood R, Taheri S, Estrada EY, Rosenberg GA (2007) Quantitative evaluation of the effect of propylene glycol on BBB permeability. J Magn Reson Imaging 25:39-47
29. Sood RR, Taheri S, Candelario-Jalil E, Estrada EY, Rosenberg GA (2008) Early beneficial effect of matrix metalloproteinase inhibition on blood-brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-term recovery after stroke in rat brain. J Cereb Blood Flow Metab 28:431-8
30. Stevens DA, Denning DW, Shatsky S, Armstrong RW, Adler JD, Lewis BH (1999) Cryptococcal meningitis in the immunocompromised host: intracranial hypertension and other complications. Mycopathologia 146:1-8
31. van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, Johnson PC, Tuazon CU, Kerkering T, Moskovitz BL, Powderly WG, Dismukes WE (1997) Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med 337:15-21
32. Wong ML, Back P, Candy G, Nelson G, Murray J (2007) Cryptococcal pneumonia in African miners at autopsy. Int J Tuberc Lung Dis 11:528-33